EYEG

Q: What is the price of EyeGate Pharmaceuticals (EYEG) today?

The price of EyeGate Pharmaceuticals (EYEG) today is $ 35.76, with return of 5.5% compared to the last year. The price of EyeGate Pharmaceuticals (EYEG) started the year trading around $ 35.77 and today it is at $ 35.76. Follow the real-time price chart, the historical price of EyeGate Pharmaceuticals (EYEG) and international markets.

Q: When does EyeGate Pharmaceuticals (EYEG) pay dividends?

EyeGate Pharmaceuticals (EYEG) distributed dividends in the last year,in the months of January and February totaling $ 0.33. The Dividend Yield for the last 12 months is 0.25%.

Q: Is EyeGate Pharmaceuticals (EYEG) worth it?

Currently, EyeGate Pharmaceuticals (EYEG) is priced at $ 35.76, with a P/E of -24.37%, representing a deviation of 0% from its historical average P/E. In the last year, the stock showed a variation of 5.5 in its price and distributed $ 0.33 in dividends, resulting in a Dividend Yield of 0.25%. The total shareholder return was 5.50%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy EyeGate Pharmaceuticals (EYEG) stock?

Investing in stocks of EyeGate Pharmaceuticals (EYEG) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of EyeGate Pharmaceuticals (EYEG) yield today?

The yield of EyeGate Pharmaceuticals (EYEG) was 0.49% in the last month, 5.50% in the last year and 646.46% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 1.77 in dividends, with a Dividend Yield of 0.25%.If you wanted to buy 100 stocks of EyeGate Pharmaceuticals (EYEG) today, the total investment would be $ 3,576.46, based on the current price of $ 35.76.If past performance were to repeat, the return on your investment would be:In 1 year: $ 3,773.17In 5 years: $ 26,696.84In 10 years: $ 2,529.27It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

EyeGate Pharmaceuticals Inc.

Price

$ 35.76

return (12m)

5.50%

p/e

-24.37

p/b

14.66

DIVIDEND YIELD

0.25%

price EYEG

EYEG

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of EYEG

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.49%

3 months

0.55%

1 year

5.50%

2 years

13.37%

5 years

646.46%

10 years

-29.28%

Fundamentals EYEG

review the fundamentals of EyeGate Pharmaceuticals shares

P/E

-24.37

Sector: -2.17 Industry: -5.92

P/S (Price-to-Sales)

10,541.91

Sector: 2.04 Industry: 3.20

P/B

14.66

Sector: 2.33 Industry: 2.50

DIVIDEND YIELD (DY)

0.25%

Sector: - Industry: -

ROA

-40.92%

Sector: -27.04% Industry: -52.76%

ROE

-60.14%

Sector: -30.90% Industry: -45.32%

ROIC

Sector: -420.29% Industry: -483.92%

NET MARGIN

-100.00%

Sector: -28.97% Industry: -34.84%

GROSS MARGIN

100.00%

Sector: 44.33% Industry: 46.29%

OPERATING MARGIN

-100.00%

Sector: -24.52% Industry: -30.48%

EV/EBITDA

-23.75

Sector: -0.57 Industry: -4.17

EV/EBIT

-23.66

Sector: -2.95 Industry: -5.95

PRICE-TO-ASSETS

9.97

Sector: 1.23 Industry: 1.45

BVPS

2.46

Sector: 3.48 Industry: 1.66

EPS

-1.48

Sector: -0.89 Industry: -1.30

EQUITY-TO-ASSETS RATIO

0.68

Sector: 0.42 Industry: 0.46

LIABILITIES / ASSETS

0.68

Sector: 0.47 Industry: 0.43

CAGR REVENUE 5 YEARS

14.87%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

5.41%

Sector: - Industry: -

Fundamentals EYEG

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/b	ROE	dy	market cap	net margin
LLY	45.62	39.48	86.53%	0.57%	$ 941.53 B	31.66%
ISRG	62.59	9.96	15.92%	0.00%	$ 178.75 B	28.38%
TMO	29.23	3.66	12.52%	0.33%	$ 195.94 B	15.05%
SNY	13.02	1.41	10.86%	4.55%	$ 118.78 B	18.68%
NVS	22.66	6.81	30.04%	2.34%	$ 316.95 B	24.67%
ABT	31.01	3.95	12.73%	2.06%	$ 202.33 B	14.72%
MDT	27.16	2.55	9.38%	2.90%	$ 125.30 B	13.00%
GSK	15.59	5.57	35.71%	2.82%	$ 118.88 B	17.48%
CVS	57.39	1.35	2.35%	3.33%	$ 101.47 B	0.44%
BSX	39.33	0.00	0.00%	0.00%	$ 113.97 B	14.44%
TMDX	53.82	13.90	25.84%	0.00%	$ 4.94 B	16.20%
HCA	17.80	-43.58	-244.82%	0.54%	$ 120.77 B	8.97%
IDXX	49.59	32.73	65.99%	0.00%	$ 52.54 B	24.62%
RMD	25.12	5.91	23.51%	0.88%	$ 37.33 B	27.53%
DHR	41.21	2.83	6.88%	0.61%	$ 148.92 B	14.71%
INMD	9.23	1.27	13.73%	0.00%	$ 866.25 M	25.32%
FMS	11.89	0.80	6.75%	3.35%	$ 13.42 B	5.02%
PHG	29.32	2.36	8.06%	2.77%	$ 30.42 B	5.07%
SYK	45.72	6.62	14.48%	0.88%	$ 148.40 B	12.92%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

EYEG Historical Dividends

current DY: 0.25%

5-year average DY: 0.25%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividend	03/02/2026	03/05/2026	0,13930000
Dividend	02/02/2026	02/05/2026	0,14110000
Dividend	12/31/2025	01/05/2026	0,18530000
Dividend	12/01/2025	12/04/2025	0,13910000
Dividend	11/03/2025	11/06/2025	0,13860000
Dividend	10/01/2025	10/06/2025	0,13610000
Dividend	09/02/2025	09/05/2025	0,14170000
Dividend	08/01/2025	08/06/2025	0,14980000
Dividend	07/01/2025	07/07/2025	0,14200000
Dividend	06/02/2025	06/05/2025	0,15100000
Dividend	05/01/2025	05/06/2025	0,15010000
Dividend	04/01/2025	04/04/2025	0,15300000
Dividend	03/03/2025	03/06/2025	0,13900000
Dividend	02/03/2025	02/06/2025	0,14100000
Dividend	12/30/2024	01/02/2025	0,47100000
Dividend	12/02/2024	12/05/2024	0,14600000
Dividend	11/01/2024	11/06/2024	0,15150000
Dividend	10/01/2024	10/04/2024	0,14750000
Dividend	09/03/2024	09/06/2024	0,14920000
Dividend	08/01/2024	08/06/2024	0,15460000
Dividend	07/01/2024	07/05/2024	0,14990000
Dividend	06/03/2024	06/06/2024	0,15390000
Dividend	05/02/2024	05/07/2024	0,14840000
Dividend	04/02/2024	04/05/2024	0,15720000
Dividend	03/04/2024	03/07/2024	0,14860000
Dividend	02/02/2024	02/07/2024	0,14760000
Dividend	12/29/2023	01/04/2024	0,09130000

ABOUT THE COMPANY EyeGate Pharmaceuticals

EyeGate Pharmaceuticals Inc.

Average user rating I10

4.0 (0 people)

United States

28 years

Founded: 1998

2015

Time since IPO - 11 years

14

Employees

The Company EyeGate Pharmaceuticals Inc. (United States), is listed on Nasdaq with a market value of $ 254.25 Millions, having an equity of $ 17.35 Millions.

With a total of 14 employees, the company is listed in the sector of Health and categorized in industry of Pharmaceutical Products.

In the last 12 months the Company had a revenue of $ 24.12 Thousand, which generated a loss in the amount of $ -10.43 Millions.

As for its main indicators, the Company has a P/E ratio of -24.37, a P/BV ratio of 14.66 and in the last 12 months the dividend yield of EYEG was at 0.25%.

The Company is traded internationally through the ticker EYEG.

Market cap

$ 254.25 Millions

Net worth

$ 17.35 Millions

US$ 17,348,046.00

Assets

$ 25.49 Millions

US$ 25,493,339.00

Total Shares Outstanding

7.06 Millions

7,062,000

Average Daily Trading Volume

$ 3.27 Millions

US$ 3,273,730.00

Sector

Health

Industry

Pharmaceutical Products

EYEG

EYEG revenue and profits

Financial Results EYEG

DRAG THE FRAME TO SEE MORE DATA

EYEG cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/B

0.00

CVS - CVS Health

$ 81.66 30,62% (12M)

P/E

57.39

3.33%

ROE

2.35%

P/B

1.35

CI - Cigna

$ 290.85 --4,20% (12M)

P/E

11.22

2.08%

ROE

0.00%

P/B

0.00

CNC - Centene

$ 44.60 --23,88% (12M)

P/E

-3.31

0.00%

ROE

-33.28%

P/B

1.10

HUM - Humana

$ 187.28 --27,05% (12M)

P/E

17.71

1.86%

ROE

6.95%

P/B

1.23

HCA - HCA Healthcare

$ 532.92 72,76% (12M)

P/E

17.80

0.54%

ROE

-244.82%

P/B

-43.58

LLY - Eli Lilly

$ 1,017.97 10,49% (12M)

P/E

45.62

0.57%

ROE

86.53%

P/B

39.48

NVS - Novartis

$ 166.87 59,21% (12M)

P/E

22.66

2.34%

ROE

30.04%

P/B

6.81